Home › Trial NCT03677076
Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer
- Trial IDNCT03677076
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorMedical University of South Carolina
- Enrollment14
- Start date2019-03-04
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.